STEPHANIE JOHNSON: Open Payments
NPI 1255647061 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 71 payments from 30 companies in 2025. Trend: 2023 $1,846 · 2024 $1,452 · 2025 $1,539
Food & beverage: $1,455Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $226 |
| Janssen Biotech, Inc. | 4 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $97 |
| UCB, Inc. | 4 | $91 |
| ARGENX US, INC. | 5 | $91 |
| Genentech USA, Inc. | 4 | $91 |
| Amgen Inc. | 3 | $78 |
| TG Therapeutics, Inc. | 4 | $62 |
| CSL Behring | 3 | $53 |
Products named: BOTOX, HYQVIA, FYCOMPA, Ocrevus Zunovo, UPLIZNA, VYVGART, UBRELVY, BRIUMVI.
Industry payments across KY — which companies pay providers there.
